SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Agency: National Institutes of Health
Assistance Listings: 93.394 -- Cancer Detection and Diagnosis Research
93.395 -- Cancer Treatment Research
Description
Eligibility
Eligible applicants
Business
- Small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-CA-24-022-Full-Announcement.html | RFA-CA-24-022 Full Announcement Text | Apr 23, 2024 05:13 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-022.html
Archived: September 26, 2024
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
RFA-CA-24-022
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Education
Health
Category Explanation:
History
Version:
1
Posted date:
April 23, 2024
Archive date:
September 26, 2024
